GALT (Galectin Therapeutics) Short Ratio


GALT Galectin Therapeutics Inc GALT
22 GF Score
Price $4.06
! 5 Warning Signs
View Full Analysis

What is Galectin Therapeutics Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

GALT
22GF Score
Galectin Therapeutics Inc GALT
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Galectin Therapeutics Business Description

Other Exchanges PHPN:Germany
Address 4960 Peachtree Industrial Boulevard, Suite 240, Norcross, GA, USA, 30071
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
22GF Score

Get the complete analysis for GALT

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.06
Price